(1) an overdose outreach provider may: (a) obtain an opiate antagonist dispensed on prescription by: (i) a health care provider, in accordance with Subsections 26-55-104(2) and (3); or (ii) a pharmacist or pharmacy intern, as otherwise authorized by Title 58, Chapter 17b, Pharmacy Practice Act; (b) store the opiate antagonist; and (c) furnish the opiate antagonist: (i) (A) to an individual who is at increased risk of experiencing an opiate-related drug overdose event; or (B) to a family member, friend, overdose outreach provider, or other individual who is in a position to assist an individual who is at increased risk of experiencing an opiate-related drug overdose event; and (ii) without liability for any civil damages for acts or omissions made as a result of furnishing the opiate antagonist in good faith; and

(a) obtain an opiate antagonist dispensed on prescription by: (i) a health care provider, in accordance with Subsections 26-55-104(2) and (3); or (ii) a pharmacist or pharmacy intern, as otherwise authorized by Title 58, Chapter 17b, Pharmacy Practice Act;

(i) a health care provider, in accordance with Subsections 26-55-104(2) and (3); or

(ii) a pharmacist or pharmacy intern, as otherwise authorized by Title 58, Chapter 17b, Pharmacy Practice Act;

(b) store the opiate antagonist; and

(c) furnish the opiate antagonist: (i) (A) to an individual who is at increased risk of experiencing an opiate-related drug overdose event; or (B) to a family member, friend, overdose outreach provider, or other individual who is in a position to assist an individual who is at increased risk of experiencing an opiate-related drug overdose event; and (ii) without liability for any civil damages for acts or omissions made as a result of furnishing the opiate antagonist in good faith; and

(i) (A) to an individual who is at increased risk of experiencing an opiate-related drug overdose event; or (B) to a family member, friend, overdose outreach provider, or other individual who is in a position to assist an individual who is at increased risk of experiencing an opiate-related drug overdose event; and

(A) to an individual who is at increased risk of experiencing an opiate-related drug overdose event; or

(B) to a family member, friend, overdose outreach provider, or other individual who is in a position to assist an individual who is at increased risk of experiencing an opiate-related drug overdose event; and

(ii) without liability for any civil damages for acts or omissions made as a result of furnishing the opiate antagonist in good faith; and

(2) when furnishing an opiate antagonist under Subsection (1), an overdose outreach provider: (a) shall also furnish to the recipient of the opiate antagonist: (i) the written instruction under Subsection 26-55-104(3) received by the overdose outreach provider from the health care provider at the time the opiate antagonist was dispensed to the overdose outreach provider; or (ii) if the opiate antagonist was dispensed to the overdose outreach provider by a pharmacist or pharmacy intern, any written patient counseling under Section 58-17b-613 received by the overdose outreach provider at the time of dispensing; and (b) may provide additional instruction on how to recognize and respond appropriately to an opiate-related drug overdose event.

(a) shall also furnish to the recipient of the opiate antagonist: (i) the written instruction under Subsection 26-55-104(3) received by the overdose outreach provider from the health care provider at the time the opiate antagonist was dispensed to the overdose outreach provider; or (ii) if the opiate antagonist was dispensed to the overdose outreach provider by a pharmacist or pharmacy intern, any written patient counseling under Section 58-17b-613 received by the overdose outreach provider at the time of dispensing; and

(i) the written instruction under Subsection 26-55-104(3) received by the overdose outreach provider from the health care provider at the time the opiate antagonist was dispensed to the overdose outreach provider; or

(ii) if the opiate antagonist was dispensed to the overdose outreach provider by a pharmacist or pharmacy intern, any written patient counseling under Section 58-17b-613 received by the overdose outreach provider at the time of dispensing; and

(b) may provide additional instruction on how to recognize and respond appropriately to an opiate-related drug overdose event.